Physician

Elizenda M. Ceballos, M.D.

According to 2025 Medicare claims, Elizenda Ceballos, M.D. (NPI: 1558321182) practices ophthalmology in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Lynchburg City, VA. This provider's primary affiliated billing organization is PIEDMONT EYE CENTER, INC. (NPI: 1801857529; TIN: 54-1120525) and primary practice location at 24502-4271.

Ceballos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,240 traditional Medicare patients, billed 4,481 HCPCS/CPT codes, and received $346,944 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,363 prescription claims across 902 beneficiaries totaling $380,076 in drug costs, led by Lumigan (Bimatoprost). DME data shows 46 claims. Open Payments data shows 7 records totaling $180. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $729,907 to $380,076. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,345	5,041	$409,633
2016	1,307	5,024	$427,846
2017	1,241	4,758	$402,633
2018	1,271	4,732	$386,113
2019	1,261	4,853	$380,094
2020	1,237	4,567	$362,796
2021	1,249	4,424	$367,031
2022	1,180	4,245	$330,540
2023	1,228	4,577	$354,126
2024	1,240	4,481	$346,944

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	858	5,712	$729,907
2016	888	5,517	$714,329
2017	843	5,002	$704,687
2018	856	4,949	$738,146
2019	880	4,859	$683,642
2020	892	5,136	$692,216
2021	901	4,977	$637,086
2022	874	4,603	$590,113
2023	903	4,700	$515,409
2024	902	4,363	$380,076

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	38	38	$1,902
2016	14	14	$478
2017	25	25	$1,082
2018	64	64	$2,302
2019	68	68	$3,148
2020	13	24	$729
2021	13	14	$657
2022	49	49	$1,950
2023	16	16	$677
2024	34	46	$2,947

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	576	910	$83
92014	Established patient complete exam of visual system	478	520	$75
92083	Exam of visual field with extended testing	447	469	$43
92250	Photography of the retina	412	418	$24
92133	Imaging of optic nerve	431	442	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	56	3,687	$39,843
Alphagan P	Brimonidine Tartrate	51	3,172	$38,413
Restasis	Cyclosporine	24	1,680	$33,934
Combigan	Brimonidine Tartrate/Timolol	58	4,327	$32,607
Rhopressa	Netarsudil Mesylate	44	2,789	$29,746

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	11	12	$1,467
V2020	Frames, purchases	N	23	23	$1,090
V2203	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	N/R	11	$391

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$180	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Elizenda M. Ceballos, M.D.?

Tedicare shows public-source Medicare data for Elizenda M. Ceballos, M.D. (NPI 1558321182), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elizenda M. Ceballos, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Elizenda M. Ceballos, M.D.?

Elizenda M. Ceballos, M.D. is linked to PIEDMONT EYE CENTER, INC. (billing NPI 1801857529) in the available physician profile data.

Does Elizenda M. Ceballos, M.D. have Open Payments data?

Elizenda M. Ceballos, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.